IL13 and neoplasm: Using a well-characterized tumor toxicity assay [28], [39], we analyzed the ability of various serum samples from mice systemically sensitized to IL13-PE to block the cytotoxicity of IL13-PE against IL-13Rα2-expressing tumor cells.